Form 4/A for OMDA Omada Health, Inc.
Accepted 2026-07-08 20:19:31 ET · period of report 2026-06-22 · accession 0001610717-26-000332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAT | 2026-07-08 20:19 | 2026-06-22 | OMDA | Gracey Craig | CAO | M - OptEx | $6.57 | +2,083 | 17.5K | +13% | +$13.7K |
| DAT | 2026-07-08 20:19 | 2026-06-22 | OMDA | Gracey Craig | CAO | S - Sale+OE | $18.00 | -2,083 | 15.4K | -12% | -$37.5K |
| DAT | 2026-07-08 20:19 | 2026-06-22 | OMDA | Gracey Craig | CAO | M - OptEx | $0.00 | -2,083 | 41.7K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | M | A | 2,083 | $6.57 | 17,524 | D | — | — | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. |
| 2 | Common | Common Stock | 2026-06-22 | S | D | 2,083 | $18.00 | 15,441 | D | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-22 | M | D | 2,083 | $0.00 | 41,667 | D | $6.57 · — to 2034-10-23 | 2,083 Common Stock | (F1) This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. (F3) 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |